drugset / Trial / NCT00017056

BMS-247550 in Treating Patients With Recurrent Metastatic Stomach Cancer That Has Been Previously Treated With Chemotherapy

NCT00017056

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of BMS-247550 in treating patients who have recurrent metastatic stomach cancer that has been previously treated with chemotherapy.

Timeline

Start
2001-02
Primary completion
2002-01
Completion
2002-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Ixabepilone Small molecule Intravenous